An Individually Randomized, Placebo-controlled Trial to Measure the Protection Conferred by a Single Dose Regimen of Bivalent, Killed, Whole Cell Oral Cholera Vaccine (Shanchol™) in Dhaka, Bangladesh
Phase of Trial: Phase III
Latest Information Update: 05 May 2016
At a glance
- Drugs Cholera vaccine inactivated (Primary)
- Indications Cholera
- Focus Therapeutic Use
- Acronyms SCVB
- 05 May 2016 Results published in the New England Journal of Medicine
- 05 May 2016 Status changed from recruiting to completed according to results published in the New England Journal of Medicine.
- 05 May 2016 Primary endpoint has been met (Number of participants with a single dose regimen oral cholera vaccine Shanchol will get protection) according to results published in the New England Journal of Medicine.